Eli Lilly And Co (LLY) Given Average Recommendation of "Buy" by Brokerages


Shares of Eli Lilly And Co have earned an average recommendation of "Buy" from the twenty-two brokerages that are presently covering the firm, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company.



from Biotech News